Virological and immunological outcomes of BIC/TAF/FTC versus DTG + TDF/FTC in treatment-naïve people with HIV: a real-world study
Irish Journal of Medical Science (1971 -) · 17.11.2026
DOI: 10.1007/s11845-026-04722-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 17.11.2026. Verfasst von Yusuf Emre Ozdemir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, 34140, Istanbul, Türkiye. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to compare the effects of DTG + TDF/FTC versus BIC/TAF/FTC regimens on virological and immunological parameters in people living with HIV (PLWH).
Methods
This retrospective observational cohort analysis examined data from treatment-naïve PLWH who had been using DTG + TDF/FTC or BIC/TAF/FTC for at least one year. VS (virological suppression), VF (virological failure), and changes in CD4 count and CD4/CD8 ratio were compared between regimens at months 3, 6, 9, and 12.
Results
Of the 348 patients, 61.8% ( n = 215) were on DTG + TDF/FTC and 38.2% ( n = 133) were on BIC/TAF/FTC. At six months, VS was 80.6% in the DTG + TDF/FTC group and 68.5% in the BIC/TAF/FTC group ( p = 0.015); VF was 9.1% in the DTG + TDF/FTC group and 8.1% in the BIC/TAF/FTC group ( p = 0.742). Among PLWH with high viral load, VS was higher in the DTG + TDF/FTC group (79.9% vs. 63.5%, p = 0.006), while VF was similar between the two groups (10.4% vs. 9.4%, p = 0.810). Immunological response rates were 91.6% in the DTG + TDF/FTC group and 87.9% in the BIC/TAF/FTC group ( p = 0.264). While the amount of increase in CD4 count at 12 months was similar in both groups ( p = 0.269), the increase in CD4/CD8 ratio was higher in the BIC/TAF/FTC group ( p = 0.007).
Conclusion
VF rates were comparably low with both regimens. However, among PLWH with high baseline viral load, DTG + TDF/FTC achieved higher VS at earlier follow-up visits. In the overall cohort, BIC/TAF/FTC produced a greater increase in the CD4/CD8 ratio. Therefore, baseline clinical characteristics should be carefully considered when selecting antiretroviral therapy, and long-term outcomes should be closely monitored to optimise treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, 34140, Istanbul, Türkiye.
- Department of Infectious Diseases and Clinical Microbiology, Medipol Bahçelievler University Hospital, 34180, Istanbul, Türkiye.
- Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, 34140, Istanbul, Türkiye. samihaulufer66@gmail.com.
Zitieren
APA
Ozdemir, Y. E., Camber, L., Ertay, B. N. O., Senoglu, S., Akkaya, S., Borcak, D., Sezen, A. I., Erdem, F. B., & Yasar, K. K. (2026). Virological and immunological outcomes of BIC/TAF/FTC versus DTG + TDF/FTC in treatment-naïve people with HIV: a real-world study. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-026-04722-3
Vancouver
Ozdemir YE, Camber L, Ertay BNO, Senoglu S, Akkaya S, Borcak D, et al. Virological and immunological outcomes of BIC/TAF/FTC versus DTG + TDF/FTC in treatment-naïve people with HIV: a real-world study. Irish Journal of Medical Science (1971 -). 2026. doi:10.1007/s11845-026-04722-3
BibTeX
@article{Ozdemir2026,
author = {Ozdemir, Yusuf Emre and Camber, Laden and Ertay, Busra Nur Ozkan and Senoglu, Sevtap and Akkaya, Samiha and Borcak, Deniz and Sezen, Aysegul Inci and Erdem, Fatma Bayrak and Yasar, Kadriye Kart},
title = {Virological and immunological outcomes of BIC/TAF/FTC versus DTG + TDF/FTC in treatment-naïve people with HIV: a real-world study},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
doi = {10.1007/s11845-026-04722-3}
}
EUVIMED